Aug 02, 2023
214:209
For every 209 shares held, investors received 214. The price per share adjusted from $106.45 to $103.96.
The split itself did not change the total investment value.
Piramal Pharma Limited (NSE:PPLPHARMA) operates in the Pharmaceuticals: major industry.
Piramal Pharma Limited company overviewPiramal Pharma Limited's most recent stock split was on August 2, 2023. It was a 214-for-209 forward split, so shareholders received 214 shares for every 209 they held.
Piramal Pharma Limited has split its stock once. This history records one forward split, on August 2, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Piramal Pharma Limited's 214-for-209 split on August 2, 2023, every 209 shares became 214 shares.
Piramal Pharma Limited has not announced a new split in our records. Its most recent split was on August 2, 2023, 3 years ago. Companies announce splits in advance, and any new NSE:PPLPHARMA split will appear on this page.
Already premium?